


Long-Term Safety of Baricitinib for RA

Upadacitinib Meets Study Endpoints to Treat RA

• By Thomas R. Collins
Visit the official website for the American College of Rheumatology.
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.